Clinical Trial: Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07311772) titled 'Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid' on Dec. 11, 2025.

Brief Summary: To explore the efficacy of Houyanqing Oral Liquid combined with conventional treatment in preventing and treating radiation-induced oral mucositis, so as to improve the quality of life of nasopharyngeal carcinoma patients received radiotherapy.

Study Start Date: Dec. 15, 2025

Study Type: INTERVENTIONAL

Condition: Nasopharyngeal Cancinoma (NPC) Radiation-induced Oral Mucositis

Intervention: DRUG: Houyanqing Oral Liquid

Houyanqing Oral Liquid is a Chinese herbal preparation formulated with Achyranthes...